NIVABUPA

The company reported a 31.2 percent year-on-year (YoY) increase in net profit, at Rs 206 crore for the quarter ended March 31, 2025, compared to Rs 157 crore in the same quarter last year. Gross Written Premium (GWP) for Q4FY25 stood at Rs 2,395 crore, registering a 36 percent YoY rise. Niva Bupa also expanded its retail health market share from 9.1 percent in FY24 to 9.4 percent in FY25, further cementing its position among the leading players in the Indian health insurance ***** the road ahead, the company said it intends to invest in building a strong and distinctive brand, accelerating digital transformation, and widening its distribution footprint to strengthen its market position and provide enhanced healthcare protection to millions of Indians. “Our focus remains on innovating for the customer, simplifying the claims process, and strengthening our digital backbone to drive further efficiencies and scalability,” the company said in its Q4 earnings filing. Motilal Oswal initiated coverage on the stock with a ‘Buy’ rating and a target price of Rs 100, citing robust growth potential. Earlier, ICICI Securities also started coverage with a ‘Buy’ rating and a target price of Rs 90. The brokerage pointed out that Niva Bupa stands to benefit from India’s still underpenetrated health insurance market,with its retail market share rising from 4 percent in FY19 to 9.4 percent in the first eleven months of FY25.